Yuvraj

BioAsia 2013 concludes with international partnerships impactful discussions on promoting Biosimilars & Biologics

The 10th edition of BioAsia, BioAsia 2013, Asia’s biggest technology and bio-business platform, which commenced on 28th January 2013 concluded on Wednesday. ...

AstraZeneca to establish strategic R&D centres

AstraZeneca has announced plans to invest in strategic research and development centres in the UK, the US and Sweden to improve pipeline productivity...

Adocia announces its phase III development program for the treatment of diabetic foot ulcer

Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins announces today the  phase III development...

Eli Lilly reports positive data from Phase III study of Cialis

Eli Lilly and Company has reported positive data from the Phase III study of Cialis/finasteride in men with lower urinary tract symptoms of...

RaySearch unveils new version of RayStation treatment planning system

RaySearch Laboratories has launched a new version of its RayStation treatment planning system for clinical use in the European Union, the US, Japan...

Medrio offers free EDC Software to university researchers

Medrio, a US-based integrated eClinical software manufacturer, is offering its web-based Electronic Data Capture (EDC) Software for Clinical Research to universities under its...

Sunshine looking for CMOs for breast cancer drug Adva-27a manufacturing

Sunshine Biopharma has started discussions with contract manufacturing organizations (CMOs) for the production of its multidrug-resistant breast cancer drug, Adva-27a. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read